Show
Sort by
-
- Journal Article
- A1
- open access
Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma
-
- Journal Article
- A1
- open access
Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies : an update of the pivotal clinical trial data
-
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma
-
- Journal Article
- A1
- open access
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
-
Identification of candidate oncogenes and chromosomal breakpoint sequencing by targeted locus amplification in T-cell acute lymphoblastic leukemia
-
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma
-
H3K27me3 erasers, novel targets in T-cell acute lymphoblastic leukaemia
-
H3K27me3 erasers are novel targets in T-cell lymphoblastic leukaemia
-
- Journal Article
- A1
- open access
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia